Tilray, Inc.

Tilray, Inc. (NASDAQ: TLRY) is engaged in researching, cultivating, and distributing medical cannabis. It is also a global distributer of cannabis lifestyle and consumer packaged goods. 

Key Highlights

• The company reported a YoY growth of 25.27% in revenue to USD 142.24 million in Q4FY21 (ended May 31, 2021) compared to USD 113.54 million in Q4FY20.
• TLRY reported a net income of USD 33.61 million in Q4FY21 in contrast to a net loss of USD 84.31 million in Q4FY20.
• At a special meeting on Sep 10, 2021, TLRY’s shareholders approved, increase in number of authorized shares. These additional shares will enable TLRY to carry out its strategic plan and accelerate growth and value creation.
• Its Debt/Equity ratio as of Q2FY21 was 0.21x.
• Its Q4FY21 ROE is -14.7%, whereas Peer’s Median stood at 2.6%.
• Stock is currently trading below both its 50-DMA and 200-DMA- a bearish indicator.
• Stock is currently leaning towards the lower end of the 52-week range of USD 4.41 to USD 67.0.
• TLRY's share price fell 8.31% in the past month.

Technical Price Chart (as of September 15, 2021). Analysis by Kalkine

Conclusion: Considering the significant topline growth, the surge in profitability, and associated risks, we recommend a "Watch" rating on the stock at the closing price of USD 12.03, up 2.47% as of September 15, 2021.

*The reference data in this report has been partly sourced from REFINITIV.

Disclaimer - This report has been issued by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and prepared by Kalkine and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine.

Any advice provided in this report is general advice only and does not take into account your objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine reports. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product.

You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice in this report or on the Kalkine website. Not all investments are appropriate for all people.

The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites. All information represents our views at the date of publication and may change without notice.

Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this report, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law, to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

On the date of publishing this report (referred to on the Kalkine website), employees and/or associates of Kalkine and its related entities do not hold interests in any of the securities or other financial products covered on the Kalkine website.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.